Pharmacy Voice chief executive Rob Darracott explains what the lobbying group and the sector need to do to maintain momentum now that the consultation on funding cuts in England has ended.
Pharmacy representatives and politicians joined forces last month to hand in a petition against the cuts, signed by 1.8 million people and timed to coincide with the final day of a government consultation on the sector's funding.
Mr Darracott told C+D on Monday (June 13) that the campaign against the funding cuts has not "made much impact" on the pharmacy minister so far.
The views and opinions discussed during this video news blog represent those of the speakers and not of Actavis UK Ltd Actavis
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events can also be reported to Actavis on 01271 385257
* ‘Patient safety is Actavis’ primary concern and we encourage healthcare professionals and patients to report any adverse event which may occur in relation to an Actavis product. An adverse event includes reports of any side effect, product misuse, abuse or overdose, including inappropriate use by children or women who are pregnant or breast-feeding. It also includes reports of a product that was used for something other than the intended purpose or was ineffective, or was given with another medicine. Complaints relating to the product can also be reported.’